Showing 2,881 - 2,900 results of 63,920 for search '(( 5 ((wt decrease) OR (we decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.34s Refine Results
  1. 2881

    Data_Sheet_1_Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA.do... by Rebeca Hid Cadena (6956792)

    Published 2019
    “…Our study shows that frequencies of CD80/CD86+ and VISTA+ monocytes were decreased in treated GCA patients only. Moreover, proportions of PD-1+ and VISTA+ Th cells were significantly decreased in GCA patients. …”
  2. 2882

    Mechanistic Insight of Synthesized 1,4-Dihydropyridines as an Antidiabetic Sword against Reactive Oxygen Species by Peter A. Sidhom (14313061)

    Published 2022
    “…Also, compound <b>8b</b> decreased blood glucose by α-glucosidase inhibition (IC<sub>50</sub> = 4.48 ± 0.32 μM), compared to acarbose (7.40 ± 0.41 μM), based selectively on the plasma window of <b>8b</b>. …”
  3. 2883
  4. 2884

    K<sub>ATP</sub> channel activity in pancreatic β-cells from WT and ERβ−/− mice in presence of 1 nM BPA. by Sergi Soriano (184947)

    Published 2012
    “…<p>A, BPA at 1 nM decreased K<sub>ATP</sub> channel activity in pancreatic β-cells from WT mice. …”
  5. 2885

    Image_5_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…Mean REE% was higher in children with non-syndromic genetic obesity (107.4% ± 12.7) and lower in children with hypothalamic obesity (87.6% ± 14.2) compared to multifactorial obesity (100.5% ± 12.6, both p<0.01). In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). …”
  6. 2886
  7. 2887
  8. 2888
  9. 2889
  10. 2890
  11. 2891
  12. 2892

    Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner by Khondoker Alam (1443499)

    Published 2017
    “…Pretreatment with bortezomib (50–250 nM, 2–7 h) significantly decreased transport of [<sup>3</sup>H]CCK-8, a specific OATP1B3 substrate, in HEK293-OATP1B3 and human sandwich-cultured hepatocytes (SCH). …”
  13. 2893

    Bcl-xL protein levels were decreased in response to siRNA transfection in A549, SK-LU1 and NP-69 cells. by Norahayu Othman (495150)

    Published 2013
    “…<p>(<b>A</b>) Western blot indicating a significant decrease in Bcl-xL protein levels in comparison to non-transfected cells 48 h post-transfection. …”
  14. 2894

    Methodology. by Scott John (228011)

    Published 2024
    “…Upon binding of lactate YFP and CFP move farther apart, the intensity of YFP fluorescence decreases while that of CFP increases. This leads to a decrease in the YFP/CFP FRET ratio. …”
  15. 2895
  16. 2896

    Western-blot and BN-PAGE analyses of brain mitochondria from WT and AOX mice. by Riyad El-Khoury (104865)

    Published 2013
    “…<p>A, Western-blot analyses of the steady state of different RC complexes (CI, NDUFA12; CII, SDHA; CIII, Core1; CIV, Cox1 and, CV, ß-ATPase) of mitochondria extracted from 11 organs from four WT and four AOX mice. B, RC complexes (I, III, IV and V) from three different organs, highly (brain), mildly (heart) and weakly (liver) expressing the AOX, were quantified as a ratio to complex II with no significant difference being observed between WT and AOX mice. …”
  17. 2897
  18. 2898

    Atrial and ventricular connexins and sodium channel genes expression levels in wt and Ts65Dn mice. by Matthieu Raveau (160575)

    Published 2012
    “…Mean±sem with Student t-test <i>P</i>-values, N = 7 and 5 for Ts65Dn and wt respectively.</p>…”
  19. 2899
  20. 2900

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    “…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i><sub>d,RIPK1</sub> = 8.6 nM, <i>K</i><sub>d,RIPK3</sub> > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC<sub>50</sub> = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …”